"A class of drugs commonly used to treat heart problems has been linked with a "modestly" increased risk of cancer. Analysis of published data from all trials of angiotensin-receptor blockers (ARBs) found one extra case of cancer for every 105 patients treated. The US researchers said the evidence from nine trials should prompt drug regulators to investigate. But they advised people not to stop taking the drugs, but to see their doctors if concerned. The results are published in The Lancet Oncology. ARBs are mainly prescribed for conditions such as high blood pressure and heart failure. They are used by millions of people worldwide" - BBCThis is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Tuesday, June 15, 2010
Cancer link to common heart drugs
"A class of drugs commonly used to treat heart problems has been linked with a "modestly" increased risk of cancer. Analysis of published data from all trials of angiotensin-receptor blockers (ARBs) found one extra case of cancer for every 105 patients treated. The US researchers said the evidence from nine trials should prompt drug regulators to investigate. But they advised people not to stop taking the drugs, but to see their doctors if concerned. The results are published in The Lancet Oncology. ARBs are mainly prescribed for conditions such as high blood pressure and heart failure. They are used by millions of people worldwide" - BBC
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment